Several studies are currently underway to evaluate small molecule-based gene switches for various cell-based interventions to reduce therapy-related toxicities, while also increasing effector cell proliferation and lifespan extension of adoptive cell therapies. Driven by the increasing adoption of gene switches to overcome the safety-related concerns associated with engineered cell therapies, this market is likely to witness significant growth in the future.
The financial opportunity within the gene switch market has been analyzed across the following segments:
- Application Area
- Management of Treatment Related Toxicity
- Regulation of Gene Expression
- Other Applications
- Type of Target Therapy
- CAR-T cell Therapies
- Gene therapies
- Other Therapies
- Type of Payment Model Employed
- Upfront Payment
- Milestone Payment
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Rest of the World
The Gene Switch/ Molecular Switch Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
- aceRNA technologies
- Autolus Therapeutics
- Bellicum Pharmaceuticals
- Cellectis
- Kiromic BioPharma
- panCELLa
- Precigen
- Sana Biotechnology
- Sangamo Therapeutics
Table of Contents
- Executive Summary
- Introduction
- Market Landscape
- Gene Switch Platforms: Product Competitiveness Analysis
- Company Profiles: Gene Switch Platform Developers
- Partnerships and Collaborations
- Funding and Investment Analysis
- Publication Analysis
- Patent Analysis
- Business Model Analysis
- Market Forecast and Opportunity Analysis
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/gene-switch-market.html
Learn from experts: do you know about these emerging industry trends?
Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Learn from our recently published whitepaper:-
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
